Published in PLoS One on February 28, 2013
Iodine-125 induces apoptosis via regulating p53, microvessel density, and vascular endothelial growth factor in colorectal cancer. World J Surg Oncol (2014) 0.77
Chemoembolization and stenting combined with iodine-125 seed strands for the treatment of hepatocellular carcinoma with inferior vena cava obstruction. Exp Ther Med (2015) 0.75
Efficacy and safety of endoscopic ultrasonography-guided interventional treatment for refractory malignant left-sided liver tumors: a case series of 26 patients. Sci Rep (2016) 0.75
Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine. Med Phys (1995) 8.87
Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. N Engl J Med (1996) 6.01
Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet (2000) 4.60
Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg (2000) 4.44
Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial. Lancet (1999) 3.54
Systematic review: evidence-based management of hepatocellular carcinoma--an updated analysis of randomized controlled trials. Aliment Pharmacol Ther (2006) 2.63
Predictors and patterns of recurrence after resection of hepatocellular carcinoma. J Am Coll Surg (2003) 1.97
Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma. Cancer (1997) 1.83
A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma. Ann Surg (2007) 1.63
Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial. J Cancer Res Clin Oncol (2006) 1.60
Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial. Arch Surg (1998) 1.54
Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials. Lancet Oncol (2002) 1.52
Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma. Am J Surg (1995) 1.33
The biological effect of 125I seed continuous low dose rate irradiation in CL187 cells. J Exp Clin Cancer Res (2009) 1.22
Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma. Cochrane Database Syst Rev (2009) 1.20
Iodine-125 brachytherapy in the treatment of colorectal adenocarcinoma metastatic to the liver. Cancer (1999) 1.11
Particle embolization of recurrent hepatocellular carcinoma after hepatectomy. Cancer (2006) 1.09
Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver. Arch Surg (2004) 1.06
Long-term follow-up of patients of intrahepatic malignancies treated with iodine-125 brachytherapy. Int J Radiat Oncol Biol Phys (2005) 1.05
Endovascular placement of iodine-125 seed strand and stent combined with chemoembolization for treatment of hepatocellular carcinoma with tumor thrombus in main portal vein. J Vasc Interv Radiol (2011) 1.05
[CT guided radioactive 125I seed implantation in treating localized advanced pulmonary carcinoma]. Zhonghua Yi Xue Za Zhi (2007) 0.95
Ultrasonically guided percutaneous implantation of iodine-125 seeds in pancreatic carcinoma. Int J Radiat Oncol Biol Phys (1990) 0.90
Microdosimetric evaluation of relative biological effectiveness for 103Pd, 125I, 241Am, and 192Ir brachytherapy sources. Int J Radiat Oncol Biol Phys (1996) 0.89
Surgical resection and permanent iodine-125 brachytherapy for brain metastases. J Neurooncol (2008) 0.88
Efficacy of therapy for hepatocellular carcinoma with portal vein tumor thrombus: chemoembolization and stent combined with iodine-125 seed. Cancer Biol Ther (2011) 0.87
Treatment of liver metastases from colorectal cancer with radioactive implants. Cancer (1994) 0.85
Modern brachytherapy for treatment of prostate cancer. Cancer Control (2007) 0.83
Irradiation induces G2/M cell cycle arrest and apoptosis in p53-deficient lymphoblastic leukemia cells without affecting Bcl-2 and Bax expression. Cell Death Differ (1998) 0.83
Buried emanation; the development of seeds for permanent implantation. Brachytherapy (2002) 0.82
[Immunological influence of iodine-125 implantation in patients with hepatocellular carcinoma resection]. Nan Fang Yi Ke Da Xue Xue Bao (2010) 0.81
Excellent functional outcome in patients with squamous cell carcinoma of the base of tongue treated with external irradiation and interstitial iodine 125 boost. Cancer (1996) 0.81
Local management of pancreatic carcinoma: iodine-125 implantation. Clin Oncol (R Coll Radiol) (1990) 0.78
The impact of temporary iodine-125 interstitial implant boost in the primary management of squamous cell carcinoma of the oropharynx. Head Neck (1997) 0.77
Intraoperative adjuvant radiotherapy for advanced cancers of the head and neck. Preliminary report. Am J Surg (1985) 0.77
Shock-synthesized hexagonal diamonds in Younger Dryas boundary sediments. Proc Natl Acad Sci U S A (2009) 3.33
Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol (2013) 2.16
Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice. Hepatology (2011) 2.13
The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma. J Hepatol (2008) 1.88
GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers. PLoS Genet (2012) 1.86
Integrated profiling of microRNAs and mRNAs: microRNAs located on Xq27.3 associate with clear cell renal cell carcinoma. PLoS One (2010) 1.82
Myocardial ischemia results in tetrahydrobiopterin (BH4) oxidation with impaired endothelial function ameliorated by BH4. Proc Natl Acad Sci U S A (2007) 1.78
Spatial localization of bacteria controls coagulation of human blood by 'quorum acting'. Nat Chem Biol (2008) 1.74
Heat shock protein 90 as an endogenous protein enhancer of inducible nitric-oxide synthase. J Biol Chem (2003) 1.41
Hypoxia-induced autophagy contributes to the chemoresistance of hepatocellular carcinoma cells. Autophagy (2009) 1.39
Retracted Comparison of the sagittal profiles among thoracic idiopathic scoliosis patients with different Cobb angles and growth potentials. J Orthop Surg Res (2014) 1.39
Modular chemical mechanism predicts spatiotemporal dynamics of initiation in the complex network of hemostasis. Proc Natl Acad Sci U S A (2006) 1.36
Antiviral therapy improves postoperative survival in patients with hepatocellular carcinoma: a randomized controlled trial. Ann Surg (2015) 1.33
Theoretical design and analysis of multivolume digital assays with wide dynamic range validated experimentally with microfluidic digital PCR. Anal Chem (2011) 1.32
Adverse ventricular remodeling and exacerbated NOS uncoupling from pressure-overload in mice lacking the beta3-adrenoreceptor. J Mol Cell Cardiol (2009) 1.24
p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1α pathways. Hepatology (2010) 1.21
Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells. Cancer Res (2008) 1.21
Overexpression of aspartyl-(asparaginyl)-beta-hydroxylase in hepatocellular carcinoma is associated with worse surgical outcome. Hepatology (2010) 1.21
Role of dimethylarginine dimethylaminohydrolases in the regulation of endothelial nitric oxide production. J Biol Chem (2009) 1.19
RNA-Seq analyses generate comprehensive transcriptomic landscape and reveal complex transcript patterns in hepatocellular carcinoma. PLoS One (2011) 1.18
Traditional herbal medicine in preventing recurrence after resection of small hepatocellular carcinoma: a multicenter randomized controlled trial. J Integr Med (2013) 1.17
Progress in research of liver surgery in China. World J Gastroenterol (2000) 1.17
Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels. Ann Surg (2013) 1.16
Characterization of the threshold response of initiation of blood clotting to stimulus patch size. Biophys J (2007) 1.15
Controlled attenuation parameter for noninvasive assessment of hepatic steatosis using Fibroscan®: validation in chronic hepatitis B. Dig Dis Sci (2014) 1.13
Critical role of TRPC6 channels in VEGF-mediated angiogenesis. Cancer Lett (2009) 1.12
CpG island methylator phenotype association with upregulated telomerase activity in hepatocellular carcinoma. Int J Cancer (2008) 1.11
Adjuvant therapy with capecitabine postpones recurrence of hepatocellular carcinoma after curative resection: a randomized controlled trial. Ann Surg Oncol (2010) 1.10
The critical role of CD133(+)CD44(+/high) tumor cells in hematogenous metastasis of liver cancers. Cell Res (2011) 1.10
Appeal from Chinese doctors to end violence. Lancet (2013) 1.09
MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive hepatocellular carcinomas in patients. Gastroenterology (2013) 1.05
Influence of interchannel spacing on the dynamical properties of multichannel quartz crystal microbalance. IEEE Trans Ultrason Ferroelectr Freq Control (2004) 1.05
Role of DDAH-1 in lipid peroxidation product-mediated inhibition of endothelial NO generation. Am J Physiol Cell Physiol (2007) 1.04
Proteasome inhibition down-regulates endothelial nitric-oxide synthase phosphorylation and function. J Biol Chem (2006) 1.04
Regulation of endothelial nitric-oxide synthase activity through phosphorylation in response to epoxyeicosatrienoic acids. Prostaglandins Other Lipid Mediat (2006) 1.04
Expression of X-linked inhibitor of apoptosis protein in human colorectal cancer and its correlation with prognosis. J Surg Oncol (2009) 1.02
Pathobiological features of small hepatocellular carcinoma: correlation between tumor size and biological behavior. J Cancer Res Clin Oncol (2010) 1.01
Inhibition of superoxide generation from neuronal nitric oxide synthase by heat shock protein 90: implications in NOS regulation. Biochemistry (2002) 1.01
Bidirectional actions of hydrogen peroxide on endothelial nitric-oxide synthase phosphorylation and function: co-commitment and interplay of Akt and AMPK. J Biol Chem (2008) 1.00
Mechanistic evaluation of the pros and cons of digital RT-LAMP for HIV-1 viral load quantification on a microfluidic device and improved efficiency via a two-step digital protocol. Anal Chem (2013) 0.99
Resveratrol reduces acute lung injury in a LPS‑induced sepsis mouse model via activation of Sirt1. Mol Med Rep (2013) 0.98
Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma. Hepatology (2012) 0.98
Krüppel-like factor 8 is a new Wnt/beta-catenin signaling target gene and regulator in hepatocellular carcinoma. PLoS One (2012) 0.97
Spontaneous complete necrosis of hepatocellular carcinoma: a case report. Hepatobiliary Pancreat Dis Int (2003) 0.96
Enucleation of liver hemangiomas: is there a difference in surgical outcomes for centrally or peripherally located lesions? Am J Surg (2009) 0.96
Hepatic steatosis is highly prevalent in hepatitis B patients and negatively associated with virological factors. Dig Dis Sci (2014) 0.96
Hemorrhagic hepatic cysts mimicking biliary cystadenoma. World J Gastroenterol (2009) 0.95
Hepatic arterial iodine-131-labeled metuximab injection combined with chemoembolization for unresectable hepatocellular carcinoma: interim safety and survival data from 110 patients. Cancer Biother Radiopharm (2010) 0.95
Roles of 3-phosphoinositide-dependent kinase 1 in the regulation of endothelial nitric-oxide synthase phosphorylation and function by heat shock protein 90. J Biol Chem (2005) 0.94
β-AR blockers suppresses ER stress in cardiac hypertrophy and heart failure. PLoS One (2011) 0.93
Autophagy in hypoxia protects cancer cells against apoptosis induced by nutrient deprivation through a Beclin1-dependent way in hepatocellular carcinoma. J Cell Biochem (2011) 0.93
Analysis of the relationships between clinicopathologic factors and survival in gallbladder cancer following surgical resection with curative intent. PLoS One (2012) 0.93
miR-132 targeting cyclin E1 suppresses cell proliferation in osteosarcoma cells. Tumour Biol (2014) 0.92
Erroneous HbA1c measurements in the presence of β-thalassemia and common Chinese hemoglobin variants. Clin Chem Lab Med (2015) 0.91
Enterovirus 71-induced neurological disorders in young gerbils, Meriones unguiculatus: development and application of a neurological disease model. PLoS One (2012) 0.91
Endoplasmic reticulum Ca2+ release modulates endothelial nitric-oxide synthase via extracellular signal-regulated kinase (ERK) 1/2-mediated serine 635 phosphorylation. J Biol Chem (2011) 0.91
Effects of p-glycoprotein on steroid-induced osteonecrosis of the femoral head. Calcif Tissue Int (2010) 0.90
Inhibition of Toll-like receptor 2 reduces cardiac fibrosis by attenuating macrophage-mediated inflammation. Cardiovasc Res (2013) 0.90
[Effects of electroacupuncture on the expression of GDNF and Ret in Parkinson's disease model rats]. Zhongguo Zhen Jiu (2010) 0.89
Trigeminal neuralgia: what are the important factors for good operative outcomes with microvascular decompression. Surg Neurol (2004) 0.89
SIRT1 promotes tumorigenesis of hepatocellular carcinoma through PI3K/PTEN/AKT signaling. Oncol Rep (2012) 0.89
Hepatocellular carcinoma expressing cholangiocyte phenotype is a novel subtype with highly aggressive behavior. Ann Surg Oncol (2011) 0.88
Nitric oxide enhances Oct-4 expression in bone marrow stem cells and promotes endothelial differentiation. Eur J Pharmacol (2008) 0.88
Methylation-related silencing of p14ARF gene correlates with telomerase activity and mRNA expression of human telomerase reverse transcriptase in hepatocellular carcinoma. J Surg Oncol (2008) 0.88
Downregulating the expression of heparanase inhibits the invasion, angiogenesis and metastasis of human hepatocellular carcinoma. Biochem Biophys Res Commun (2007) 0.87
MiR-142-3p functions as a potential tumor suppressor in human osteosarcoma by targeting HMGA1. Cell Physiol Biochem (2014) 0.87
Synthesis and structure-activity relationships evaluation of benzothiazinone derivatives as potential anti-tubercular agents. Bioorg Med Chem Lett (2013) 0.87
Inhibition of FGFR signaling by PD173074 improves antitumor immunity and impairs breast cancer metastasis. Breast Cancer Res Treat (2014) 0.87
Endoplasmic reticulum stress participates in aortic valve calcification in hypercholesterolemic animals. Arterioscler Thromb Vasc Biol (2013) 0.87
The effect of rutin on arginine kinase: inhibition kinetics and thermodynamics merging with docking simulation. Int J Biol Macromol (2008) 0.86
Obligatory role of heat shock protein 90 in iNOS induction. Am J Physiol Cell Physiol (2011) 0.86
Elevated SHOX2 expression is associated with tumor recurrence of hepatocellular carcinoma. Ann Surg Oncol (2013) 0.86
Selective main portal vein clamping to minimize the risk of recurrence after curative liver resection for hepatocellular carcinoma. Hepatogastroenterology (2012) 0.85
Adiponectin and its receptors in chronic hepatitis B patients with steatosis in china. Hepat Mon (2013) 0.85
Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: a non-randomized comparative study. Hepatogastroenterology (2012) 0.85
Studies on the operative outcomes and mechanisms of microvascular decompression in treating typical and atypical trigeminal neuralgia. Clin J Pain (2005) 0.85
Early viral suppression predicts good postoperative survivals in patients with hepatocellular carcinoma with a high baseline HBV-DNA load. Ann Surg Oncol (2012) 0.85
Autophagy protects type II alveolar epithelial cells from Mycobacterium tuberculosis infection. Biochem Biophys Res Commun (2013) 0.85
Hepatic artery injection of ¹³¹I-labelled metuximab combined with chemoembolization for intermediate hepatocellular carcinoma: a prospective nonrandomized study. Eur J Nucl Med Mol Imaging (2012) 0.85
Calcineurin regulates myocardial function during acute endotoxemia. Am J Respir Crit Care Med (2006) 0.85
VEGF +405G/C (rs2010963) polymorphisms and digestive system cancer risk: a meta-analysis. Tumour Biol (2014) 0.85
Characterization of ZNF23, a KRAB-containing protein that is downregulated in human cancers and inhibits cell cycle progression. Exp Cell Res (2006) 0.85
FAM172A induces S phase arrest of HepG2 cells via Notch 3. Oncol Rep (2013) 0.84
Hybrid genetic and variational expectation-maximization algorithm for gaussian-mixture-model-based brain MR image segmentation. IEEE Trans Inf Technol Biomed (2011) 0.84
Cruciate ligament reconstruction using LARS artificial ligament under arthroscopy: 81 cases report. Chin Med J (Engl) (2010) 0.84
Response to shape emerges in a complex biochemical network and its simple chemical analogue. Angew Chem Int Ed Engl (2007) 0.84
Is Hepatic Resection for Large or Multifocal Intrahepatic Cholangiocarcinoma Justified? Results from a Multi-Institutional Collaboration. Ann Surg Oncol (2014) 0.84
The N-Glycosylation Modification of LHBs (Large Surface Proteins of HBV) Effects on Endoplasmic Reticulum Stress, Cell Proliferation and its Secretion. Hepat Mon (2013) 0.83
Patients with advanced primary hepatocellular carcinoma treated by melatonin and transcatheter arterial chemoembolization: a prospective study. Hepatobiliary Pancreat Dis Int (2002) 0.83
Body mass index and risk of primary liver cancer: a meta-analysis of prospective studies. Oncologist (2012) 0.83
The alpha subunit of the G protein G13 regulates activity of one or more Gli transcription factors independently of smoothened. J Biol Chem (2011) 0.83
The preparation and evaluation of water-soluble SKLB610 nanosuspensions with improved bioavailability. AAPS PharmSciTech (2013) 0.83
Treatment of portal vein tumor thrombus of hepatocellular carcinoma with percutaneous laser ablation. J Cancer Res Clin Oncol (2008) 0.83
Proteomics analysis of distinct portal vein tumor thrombi in hepatocellular carcinoma patients. J Proteome Res (2010) 0.83
Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and a monitor of recurrence of hepatocellular carcinoma after curative liver resection. Ann Surg Oncol (2011) 0.83
Nomograms for Pre- and Postoperative Prediction of Long-term Survival for Patients Who Underwent Hepatectomy for Multiple Hepatocellular Carcinomas. Ann Surg (2016) 0.82